Patent · US Active

Growth factor isoform

US8394930B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2010
Grant dateMar 12, 2013
Priority date—
Expiry dateApr 27, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An isolated VEGF polypeptide having anti-angiogenic activity, said polypeptide including the amino acid sequence of SEQ.ID NO.1, or variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.